Regeneron Pharmaceuticals, Inc. REGN
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Christopher Raymond | Raymond James | 577.9 $ | 673 $ | 95.10 % | 02/09/2025 |
| Mohit Bansal | Wells Fargo | 563.4252 $ | 580 $ | 16.57 % | 01/08/2025 |
| Geoff Meacham | Citigroup | 563.4252 $ | 650 $ | 86.57 % | 01/08/2025 |
| Trung Huynh | UBS | 559.76 $ | 584 $ | 24.24 % | 11/07/2025 |
| Terence Flynn | Morgan Stanley | 560.2805 $ | 754 $ | 193.72 % | 10/07/2025 |
| Terence Flynn | Morgan Stanley | 490.81 $ | 755 $ | 264.19 % | 02/06/2025 |
| Carter Gould | Cantor Fitzgerald | 585.49 $ | 695 $ | 109.51 % | 22/04/2025 |
| John Newman | Canaccord Genuity | 585.49 $ | 850 $ | 264.51 % | 22/04/2025 |
| Evan David Seigerman | BMO Capital | 843.6 $ | 1190 $ | 346.40 % | 01/11/2024 |
| Christopher Raymond | Piper Sandler | 843.6 $ | 1195 $ | 351.40 % | 01/11/2024 |
| Andrew Berens | Leerink Partners | 843.6 $ | 880 $ | 36.40 % | 01/11/2024 |
| Cory Kasimov | Evercore ISI | 838.2 $ | 1170 $ | 331.80 % | 31/10/2024 |
| Cory Kasimov | Evercore ISI | 941.39 $ | 1175 $ | 233.61 % | 24/10/2024 |
| Mohit Bansal | Wells Fargo | 962.34 $ | 1050 $ | 87.66 % | 23/10/2024 |
| Thomas Klee | Truist Financial | 1091.98 $ | 1200 $ | 108.02 % | 24/09/2024 |
| David Risinger | Leerink Partners | 1091.98 $ | 1077 $ | -14.98 % | 24/09/2024 |
| Brian Skorney | Robert W. Baird | 1091.98 $ | 940 $ | -151.98 % | 24/09/2024 |
| Salveen Richter | Goldman Sachs | 1091.98 $ | 1292 $ | 200.02 % | 24/09/2024 |
| Evan David Seigerman | BMO Capital | 1159.945 $ | 1300 $ | 140.06 % | 12/09/2024 |
| Brian Abrahams | RBC Capital | 1139.41 $ | 1282 $ | 142.59 % | 09/09/2024 |
| Christopher Raymond | Raymond James | 1187.66 $ | 1242 $ | 54.34 % | 23/08/2024 |
| Geoff Meacham | Bank of America Securities | 1077.48 $ | 805 $ | -272.48 % | 02/08/2024 |
| Brian Abrahams | RBC Capital | 1093.14 $ | 1240 $ | 146.86 % | 02/08/2024 |
| Christopher Raymond | Raymond James | 1063.6 $ | 1166 $ | 102.40 % | 19/07/2024 |
| Yatin Suneja | Guggenheim | 1085.62 $ | 1180 $ | 94.38 % | 18/07/2024 |
| Trung Huynh | UBS | 1092.3075 $ | 1250 $ | 157.69 % | 12/07/2024 |
| Terence Flynn | Morgan Stanley | 1071.12 $ | 1182 $ | 110.88 % | 11/07/2024 |
| Jasper Hellweg | Argus Research | 1063.89 $ | 1170 $ | 106.11 % | 25/06/2024 |
| Brian Abrahams | RBC Capital | 1022.03 $ | 1299 $ | 276.97 % | 13/06/2024 |
| Brian Abrahams | RBC Capital | 1010.54 $ | 1229 $ | 218.46 % | 12/06/2024 |
| Brian Abrahams | RBC Capital | 998.64 $ | 1200 $ | 201.36 % | 04/06/2024 |
| Evan David Seigerman | BMO Capital | 992.4728 $ | 1082 $ | 89.53 % | 03/06/2024 |
| Christopher Raymond | Raymond James | 982.29 $ | 1000 $ | 17.71 % | 20/05/2024 |
| Cory Kasimov | Evercore ISI | 976.96 $ | 1150 $ | 173.04 % | 13/05/2024 |
| Brian Abrahams | RBC Capital | 937.61 $ | 1185 $ | 247.39 % | 03/05/2024 |
| Akash Tewari | Jefferies | 911.78 $ | 1060 $ | 148.22 % | 12/04/2024 |
| Brian Abrahams | RBC Capital | 921.34 $ | 1189 $ | 267.66 % | 11/04/2024 |
| Matthew Harrison | Morgan Stanley | 965.47 $ | 1115 $ | 149.53 % | 13/03/2024 |
| Brian Abrahams | BMO Capital | 934.055 $ | 1076 $ | 141.95 % | 12/01/2024 |
| Brian Abrahams | RBC Capital | 933.2 $ | 1076 $ | 142.80 % | 12/01/2024 |
| Andrew Berens | Leerink Partners | 820 $ | 976 $ | 156.00 % | 27/03/2023 |
| Akash Tewari | Jefferies | 819.68 $ | 925 $ | 105.32 % | 24/03/2023 |
| Matthew Harrison | Morgan Stanley | 708.85 $ | 851 $ | 142.15 % | 09/09/2022 |
| Akash Tewari | Jefferies | 708.85 $ | 675 $ | -33.85 % | 08/09/2022 |
| Matthew Harrison | Morgan Stanley | 628.71 $ | 625 $ | -3.71 % | 15/08/2022 |
| Kennen MacKay | RBC Capital | 597.62 $ | 638 $ | 40.38 % | 29/06/2022 |
| Mohit Bansal | Wells Fargo | 571.81 $ | 735 $ | 163.19 % | 11/06/2022 |
| Geoffrey Porges | Leerink Partners | 680.22 $ | 738 $ | 57.78 % | 23/05/2022 |
| Lorenzo Biasio | Credit Suisse | 681.91 $ | 725 $ | 43.09 % | 23/05/2022 |
| Carter Gould | Barclays | 733.02 $ | 745 $ | 11.98 % | 17/04/2022 |
| Evan David Seigerman | BMO Capital | 638.41 $ | 780 $ | 141.59 % | 13/02/2022 |
| Carter Gould | Barclays | 622.36 $ | 700 $ | 77.64 % | 07/02/2022 |
| Kennen MacKay | RBC Capital | 622.96 $ | 679 $ | 56.04 % | 04/02/2022 |
| Tyler Van Buren | Cowen & Co. | 622.96 $ | 640 $ | 17.04 % | 04/02/2022 |
| Cory Kasimov | J.P. Morgan | 622.96 $ | 604 $ | -18.96 % | 04/02/2022 |
| Joshua Schimmer | Evercore ISI | 622.85 $ | 680 $ | 57.15 % | 02/02/2022 |
| Matthew Harrison | Morgan Stanley | 611.22 $ | 585 $ | -26.22 % | 18/01/2022 |
| Aaron Gal | Bernstein | 627.1 $ | 660 $ | 32.90 % | 03/01/2022 |
| Salveen Richter | Goldman Sachs | 625 $ | 824 $ | 199.00 % | 06/12/2021 |
| Alethia Young | Cantor Fitzgerald | 622.2 $ | 760 $ | 137.80 % | 10/11/2021 |
| Esther Rajavelu | UBS | 646.11 $ | 763 $ | 116.89 % | 09/09/2021 |
| Jasper Hellweg | Argus Research | 528.75 $ | 590 $ | 61.25 % | 14/06/2021 |
| John Newman | Canaccord Genuity | 506.72 $ | 700 $ | 193.28 % | 21/05/2021 |